Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Imax Corp has demonstrated resilience in its domestic screen base, which has grown slightly post-pandemic while the total industry screen base has contracted. The company's strategy is projected to yield consistent revenue growth and margin expansion, with expectations for total revenues in 2026 to reach approximately $437 million, a 9% increase over 2025. Additionally, Imax is poised for market share gains driven by an increase in filmed-for-IMAX titles, a diverse global box office relying on local and global content, and expanded opportunities in alternative content to boost revenue.

Bears say

Imax Corp faces significant headwinds due to a notable reduction in box office expectations for premium screenings, which have fallen from $20 million to $7 million, indicating shifts in consumer demand and potential revenue shortfalls. Additionally, concerns about the evolving theatrical landscape, particularly with platforms like Netflix challenging traditional release windows, threaten to further diminish audience turnout and negatively impact box office growth. The ongoing difficulties within the exhibition industry post-COVID also raise concerns about overall audience engagement, as any downturn in demand for Imax's offerings could exacerbate financial pressures on the company.

IMAX (IMAX) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 9 analysts, IMAX (IMAX) has a Buy consensus rating as of Jan 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.